Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbCellera Biologics Inc. - Common Shares
(NQ:
ABCL
)
2.095
-0.125 (-5.63%)
Streaming Delayed Price
Updated: 1:54 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbCellera Biologics Inc. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
February 28, 2023
Via
Benzinga
AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023
February 23, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Biologics (ABCL) Q4 2022 Earnings Call Transcript
February 21, 2023
ABCL earnings call for the period ending December 31, 2022.
Via
The Motley Fool
AbCellera Reports Full Year 2022 Business Results
February 21, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
Preview: AbCellera Biologics's Earnings
February 20, 2023
Via
Benzinga
The Latest Analyst Ratings for AbCellera Biologics
January 06, 2023
Via
Benzinga
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
February 02, 2023
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.
Via
InvestorPlace
AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023
February 01, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Report Full Year 2022 Financial Results on February 21, 2023
January 24, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent
January 19, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023
January 04, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
RCI Hospitality, AbCellera Biologics And Some Other Big Stocks Moving Higher On Thursday
December 15, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 600 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
AbCellera and AbbVie Partner to Advance New Antibody Therapies
December 15, 2022
From
AbCellera Biologics Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via
Benzinga
Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket
December 15, 2022
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday.
Via
Benzinga
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
December 13, 2022
Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
Via
Benzinga
Pinterest, Oracle And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
December 13, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. ACM Research, Inc. (NASDAQ: ACMR) shares jumped 25.9% to $10.98 in...
Via
Benzinga
AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases
December 01, 2022
From
Rallybio Corporation
Via
Business Wire
AbCellera Presents New Data on Further Development and Characterization of T-Cell Engager Platform at SITC 2022
November 10, 2022
From
AbCellera Biologics Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Upgrades
Via
Benzinga
Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
November 10, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 59% to $0.1619 in pre-market trading after dipping 40% on Wednesday. Fast Radius recently filed voluntary petitions for relief under Chapter 11.
Via
Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
Gainers
Via
Benzinga
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
November 10, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's...
Via
Benzinga
Coupang, Rivian Automotive And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 10, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Why Array Technologies Shares Are Trading Sharply Higher; Here Are 28 Stocks Moving Premarket
November 09, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares jumped 32% to $1.65 in pre-market trading. NeuroBo reported closing of $32.3 million underwritten public offering including full exercise of...
Via
Benzinga
AbCellera Biologics Inc. (ABCL) Q3 2022 Earnings Call Transcript
November 08, 2022
ABCL earnings call for the period ending September 30, 2022.
Via
The Motley Fool
AbCellera Reports Q3 2022 Business Results
November 08, 2022
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Present at Upcoming Investor Conferences in November
November 04, 2022
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera’s First Program with Regeneron in Multi-Target Collaboration Advances in Preclinical Development
November 02, 2022
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Report Third Quarter 2022 Financial Results on November 8, 2022
October 11, 2022
From
AbCellera Biologics Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.